Researchers found that people who had COVID-19 were about 40% more likely to develop diabetes within a year after recovering, compared to participants in a control group.
Some people have skipped care because of finances or fear of the virus, doctors say. Others find medical practices closed to new patients. Many are suffering health consequences, an NPR poll finds.
Some polls show Trump's support slipping among seniors. His new plan will help diabetic seniors limit insulin costs to $35 per month, starting next year.
Diabetes can double a person's chances of developing Alzheimer's. Now researchers are beginning to understand the role of brain metabolism in the development of the disease.
Pregnant women and people with chronic health conditions such as asthma, diabetes and heart disease are particularly vulnerable to flu complications yet lag the elderly in getting vaccinated.
Will a genetic test for Type 1 diabetes risk be valuable to parents, despite its shortcomings? Now many parents don't know their kids have this condition until they end up in the hospital.
We're all different and that's good, says the U.S. Supreme Court justice. Her new children's book about embracing diversity portrays kids of all abilities working together to create a gorgeous garden.
Software that can replace doctors for certain tasks has a big responsibility. The Food and Drug Administration is now figuring out how to determine when computer algorithms are safe and effective.
The Indianapolis-based drugmaker said Monday that it would offer a generic version of Humalog insulin, one of its best-selling medicines. The move could help blunt criticism about high prices.
A woman's health issues related to pregnancy don't always end at the baby's birth. Scientists say complications from childbirth, such as hypertension or diabetes, increase her risk of heart disease.
The price of insulin keeps going up. For people with Type 1 diabetes, high prices can be a life and death issue. Now a grassroots movement is pushing for change.
Voters in Oregon and Washington will decide Tuesday whether to strip cities of their ability to tax sugary drinks, thanks to ballot initiatives backed by Big Soda.
Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes and 26 when he died. He couldn't afford $1,300 per month for his insulin and other diabetes supplies, so he tried to stretch the doses.
Indian drugmakers like to come up with combos — two meds in one pill. They can make more money that way. And they say it's easier for patients to take one pill than two. But is there a downside?
How low should blood sugar go? A major medical society recommends less aggressive treatment for Type 2 diabetes. This controversial position goes against advice from numerous other groups.
It used to be called juvenile diabetes because it was thought to often start in childhood. But adults are just as likely to be diagnosed with Type 1 diabetes. Not knowing that can delay treatment.
People who have Type-1 diabetes would love to be free of insulin injections and pumps. Researchers in San Francisco are now testing in animals an implantable pouch of living, insulin-releasing cells.
Nevada Health and Human Services officials have named more than three dozen diabetes medications that will be covered by the state’s new law governing transparency on drug pricing.
Nearly 40 million Americans live miles away from fresh, healthy food, and participants in the "Grocery Walk" wanted to show how difficult it can be to get basic items in these often low-income areas.
The CDC says 7 million people have Type 2 diabetes and don't know it. But a new analysis says that number's much lower. Screening efforts should focus on people at highest risk, the researchers say.
While the technology is moving rapidly, insurance, regulatory, and supply challenges make it harder for patients to quickly access the latest medical advances to manage their condition.
Smoking, drug abuse and diabetes are all modifiable risk factors for stroke. Yet a large study of patients hospitalized for stroke suggests the number of people with these risk factors is rising.
